\documentclass{beamer}
\usepackage[orientation=portrait,size=a0,scale=1.4,debug]{beamerposter}
\mode<presentation>{\usetheme{TUD}}
%\usepackage{chemformula}
\usepackage[utf8]{inputenc}
\usepackage[english]{babel} % required for rendering German special characters
%\usepackage{siunitx} %pretty measurement unit rendering
\usepackage{hyperref} %enable hyperlink for urls
%\usepackage{ragged2e}
\usepackage[font=scriptsize,justification=justified]{caption}
%\usepackage{array,booktabs,tabularx}

%\newcolumntype{Z}{>{\centering\arraybackslash}X} % centered tabularx columns
%\sisetup{per=frac,fraction=sfrac}

\title{\huge Opto-fMRI of Monoaminergic Systems and Psychotropic Drugs}
\author{Horea-Ioan Ioanas$^{1,2}$, Bechara Saab$^{2}$, Markus Rudin$^{1}$}
\institute[ETH]
	{$^{1}$Institute for Biomedical Engineering, ETH and University of Zurich \\
	 $^{2}$DPPP, Psychiatric Hospital, University of Zurich}
\date{\today}

% edit this depending on how tall your header is. We should make this scaling automatic :-/
%\newlength{\columnheight}
%\setlength{\columnheight}{104cm}

\begin{document}
\begin{frame}
	\begin{tudcolumn}{.48\textwidth}
					\begin{myblock}{Introduction}
						\begin{itemize}
							\item One
							\item Two
							\item Four
						\end{itemize}

						Monoaminergic systems are ensembles of neurons defined by the 
						primary production of monoamine neurotransmitters (most prominently 
						serotonin, dopamine, and noradrenaline).
						The current project aims to establish opto-fMRI as an assay for
						monoaminergic systems.
						This assay will help ellucidate the functional mechanisms of
						psychotropic drugs, and facillitate the establishment of functional
						connectivity and inter-connectivity models for these most pervasive
						neuronal systems.
						\vspace{0.4em}
						\begin{figure}
							\begin{minipage}{0.43\textwidth}
								\centering\includegraphics[width=0.85\textwidth]{img/mas.png}
								\caption{Serotonergic (green), dopaminergic (red), and
								noradrenergic (blue) nuclei and significant projections \cite{Paivi}}
							\end{minipage}
							\hspace{1em}
							\begin{minipage}{0.45\textwidth}
								\centering\includegraphics[width=1\textwidth]{img/drn_mr_p.png}
								\caption{Ascending serotonergic projections alone innervate the
								majority of cortical and subcortical areas \cite{Oegren2008}}
							\end{minipage}
						\end{figure}
						%\vfill
					\end{myblock}
					\begin{myblock}{Chronic Serotonin Reuptake Inhibition}
						Selective Serotonin Reuptake Inhibitors (SSRI) are used in the
						treatment of depression, and have differing acute (e.g. stimulant
						and anxiogenic) and chronic (antidepressant and anxiolytic)
						effects - with the neuronal mechanism of the latter still being
						widely debated.
						Possible explanations include the down-regulation of either the
						serotonin transporter protein (SERT), and/or serotonergic
						autoreceptors (5-HT$_1$A).
						We are administering fluoxetine both chronically and acutely to a
						number of animals prepared for opto-fMRI; we present the timetable
						of the first cohort in figure~\ref{fig:tt}.
						\vspace{0.5em}
						\begin{figure}
							\begin{minipage}{0.94\textwidth}
								\centering\includegraphics[width=0.9\textwidth]{img/dm.png}
								\caption{Band-pass filtered pulse-train-resolved first-level
										design model, with pulse trains represented in cyan.}
								\label{fig:stim}
							\end{minipage}
						\end{figure}
						%\begin{itemize}
						%	\item Opto-fMRI can be used to analyze chronic SSRI effects on serotonergic neurotransmission - by modelling the effect of treatment on individual pulse trains, or the interaction effect of treatment and pulse train number on series of pulse trains (as seen in figure~\ref{fig:stim}).
						% 	\item The large-scale readout capacity of opto-fMRI can also detect whether there are regionally varying effects of chronic SSRI administration (and consequently allow a functional characterization of neuronal subpopulations of the dorsal raphe).
						%\end{itemize}
						\vspace{0.5em}
						\begin{figure}
							\begin{minipage}{0.94\textwidth}
								\centering\includegraphics[width=0.9\textwidth]{img/tt.png}
								\caption{Animal cohort treatment and measurement timetable.
										Opto-fMRI scan dates are tinted turquoise.
										Treatment-free days are shaded light gray, chronic (i.p.)
										fluoxetine administration days medium gray, and acute
										(i.v.) fluoxetine administration days dark gray.}
								\label{fig:tt}
							\end{minipage}
						\end{figure}
						
					\end{myblock}
	\end{tudcolumn}
	\begin{tudcolumn}{.48\textwidth}
					\begin{myblock}{Methods}
						For robust genotyping we have designed 2 multiplex-compatible
						primer pairs for the Cre recombinase (transgene construct) and
						GAPDH (positive control).
						These are listed below, alongside a genotyping assay featuring 3
						controls (water, known transgene, and known wildtype - on the
						first, second-to-last and last non-ladder lanes respectively):
						%\vspace{0.1em}
						%\begin{figure}
						%	\begin{minipage}{.45\textwidth}
						%		\scriptsize
						%		\begin{tabular}{@{} p{.1\linewidth} r r @{}}
						%			\toprule
						%			Direction  &      \multicolumn{2}{c @{}}{Target Construct}      \\
						%			\cmidrule(l){2-3}
						%			&   Cre       & GAPDH  \\
						%			\cmidrule(lr){1-3}
						%			fw &   \texttt{ACCAGCCAGCTATCAACTCG} & \texttt{CTCCATTTCCCCTGTTCTCC}    \\
						%			rv &   \texttt{TTGCCCCTGTTTCACTATCC} & \texttt{GAGACCTGAATGCTGCTTCC}    \\
						%			\bottomrule
						%		\end{tabular}
						%	\end{minipage}
						%	\begin{minipage}{.45\textwidth}
						%		\centering\includegraphics[width=0.95\textwidth]{img/ag1}
						%	\end{minipage}
						%\end{figure}
						%\vspace{1em}
						To facillitate multimodal and exploratory data analysis,
						LabbookDB - a relational database structure - was developed to
						replace the common lab book and integrate metadata directly with
						analysis tools.
						In order to facilitate rapid, cheap, and flexible access to the
						high computing power needed for exploratory fMRI analysis, a
						cloud-computing GNU/Linux image, NeuroGentoo was created;
						and populated with a multitude of neuroimaging package atoms.
						\vspace{0.5em}
						\begin{figure}
							\begin{minipage}{0.43\textwidth}
								\centering\includegraphics[width=0.6\textwidth]{img/ng_large.png}
								\caption{NeuroGentoo Logo; for the software repository see:
										\href{https://github.com/TheChymera/neurogentoo}{github.com/TheChymera/neurogentoo}}
							\end{minipage}
							\hspace{1em}
							\begin{minipage}{0.45\textwidth}
								\centering\includegraphics[width=0.34\textwidth]{img/db.png}
								\caption{Generic DB logo
									(\href{https://creativecommons.org/licenses/by-nc-sa/3.0/}{CC BY-NC-SA Barry Mieny});
									for the software package see:
									\href{https://github.com/TheChymera/labbookdb}{github.com/TheChymera/labbookdb}}
							\end{minipage}
						\end{figure}
					\end{myblock}%\vfill
					\begin{myblock}{Acute Fluoxetine Effects}
						Preliminary results from the comparison of the first two
						measurement sessions (as seen in figure~\ref{fig:tt}) indicate
						that the uncorrected response to optogenetic stimulation across
						all trains (depicted individually in figure~\ref{fig:stim}) is
						stronger and more widespread immediately after acute fluoxetine
						administration than in the drug-naive mouse.
						It is important to note that the results seen in
						figure~\ref{fig:fail} need further statistical ellaboration.
						\begin{figure}
							\begin{minipage}{0.85\textwidth}
								\centering\includegraphics[width=0.75\textwidth]{img/fail.png}
								\caption{Contrast for all stimulation train parameter estimates
								for the pre-drug-administration session (red) and the acute
								fluoxetine administration session (green).
								Note the considerably different scales.}
								\label{fig:fail}
							\end{minipage}
						\end{figure}
					\end{myblock}%\vfill
					\begin{myblock}{References}
						\footnotesize
						\bibliographystyle{abbrv}
						\bibliography{./bib}
					\end{myblock}%\vfill
	\end{tudcolumn}
\end{frame}
\end{document}
